Agree with your small caps commentary in general. TCN probably needs to review its guidance positions though as over promising, even if unintentional, and then revising downwards during the year does not engender confidence IMO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025